BENIGN PROSTATIC HYPERPLASIA AND PROSTATITIS
BENIGN PROSTATIC HYPERPLASIA AND PROSTATITIS
批准号:
2145010
负责人:
THOMAS G PRETLOW
金额:
$13.94万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 1995-09-29
关键词:
aging athymic mouse benign prostate hyperplasia body weight diabetes mellitus digital imaging family genetics histopathology human tissue immunocytochemistry morphology polymerase chain reaction prostate prostate neoplasms prostatitis restriction fragment length polymorphism tissue /cell culture xenotransplantation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Benign prostatic hyperplasia (BPH) is a very common disease in the aging
male. Both BPH and chronic prostatitis are pathologically imprecisely
defined. Prostatitis, as detailed in the body of this proposal, has been
described by one prominent urologist as a 'wastebasket of clinical
ignorance.' Both of these disease states (a) are more common among
diabetics and (b) involve changes in the prostate that are, at the level
of the tissue, both multiple and diverse. Attempts to understand the
pathogenesis, biochemistry, molecular biology, endocrinology, and
immunology of these lesions will be very frustrating until precise
definitions of the many diverse entities in the 'wastebasket' can be
defined. This task will be approached with the morphometric
quantification of the anatomical and pathological structures that are
observed in men starting with men in their early twenties. Alternating
serial sections of whole prostates at intervals of 0.5 cm will be
processed in paraffin and methacrylate. With corrections for differences
in tissue shrinkage with these two methods, a computer-assisted
three-dimensional image of each prostate will be constructed. The use of
methacrylate allows superior in situ hybridization and the demonstration
of most enzymes and antigens. The use of paraffin allows the recovery of
nuclei that are satisfactory for use with the polymerase chain reaction
and for flow cytometry. The frequency of each recognizable lesion will
be catalogued as a function of age. We shall then continue a study
already begun in an attempt to identify phenotypic changes that are
characteristic of each of the lesions that are observed in BPH. We have
recently describe a new method that permits the growth as xenografts of
most prostatic carcinomas (PCA). We have observed that, with this new
method for xenografting, epithelial tumors form in the xenografts of some
samples of BPH from patients without PCA; this system will be used to
determine which lesions are capable of growing as xenografts and to
define growth fractions, growth potentials, and ability to express dif-
ferentiation markers in immunologically deficient mice with and without
exogenously supplied growth factors. In preliminary experiments, we have
found in some samples of BPH multiple messages for EGF-R (similar to
those described in the A431 line of malignant cells), overexpression of
TGF-alpha, and evidence of the deletion of genes in the vicinity of
1Oq24. We shall investigate these and other markers to define
differences that distinguish these entities from each other and to better
understand the biological potentials of these entities.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
A novel approach to the characterization of whole prostate pathology in glycol methacrylate.
一种表征甲基丙烯酸乙二醇酯中整个前列腺病理学的新方法。
DOI:
--
发表时间:
1994
期刊:
The American journal of pathology
影响因子:
--
作者:
[MongerJr,LE, Nagabhushan,M, Pretlow,TG, Pretlow,TP]
通讯作者:
Pretlow,TP
CORE--HISTOLOGY FACILITY
-
批准号:6347305
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2000
-
负责人:THOMAS G PRETLOW
-
依托单位:
CORE--HISTOLOGY FACILITY
-
批准号:6346003
-
项目类别:
-
资助金额:$18.01万
-
财政年份:2000
-
负责人:THOMAS G PRETLOW
-
依托单位:
CORE--HISTOLOGY FACILITY
-
批准号:6216459
-
项目类别:
-
资助金额:$18.01万
-
财政年份:1999
-
负责人:THOMAS G PRETLOW
-
依托单位:
CORE--HISTOLOGY FACILITY
-
批准号:6295900
-
项目类别:
-
资助金额:$18.01万
-
财政年份:1999
-
负责人:THOMAS G PRETLOW
-
依托单位:
CORE--HISTOLOGY FACILITY
-
批准号:6102332
-
项目类别:
-
资助金额:$18.01万
-
财政年份:1998
-
负责人:THOMAS G PRETLOW
-
依托单位:
CORE--HISTOLOGY FACILITY
-
批准号:6269256
-
项目类别:
-
资助金额:$18.01万
-
财政年份:1998
-
负责人:THOMAS G PRETLOW
-
依托单位:
CORE--HISTOLOGY FACILITY
-
批准号:6236853
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1997
-
负责人:THOMAS G PRETLOW
-
依托单位:
PROSTATIC ENDPOINT BIOMARKERS
-
批准号:2770580
-
项目类别:
-
资助金额:$24.14万
-
财政年份:1995
-
负责人:THOMAS G PRETLOW
-
依托单位:
PROSTATIC ENDPOINT BIOMARKERS
-
批准号:2152435
-
项目类别:
-
资助金额:$21.75万
-
财政年份:1995
-
负责人:THOMAS G PRETLOW
-
依托单位:
PROSTATIC ENDPOINT BIOMARKERS
-
批准号:2017261
-
项目类别:
-
资助金额:$22.67万
-
财政年份:1995
-
负责人:THOMAS G PRETLOW
-
依托单位:
PROSTATIC ENDPOINT BIOMARKERS
-
批准号:2518546
-
项目类别:
-
资助金额:$23.39万
-
财政年份:1995
-
负责人:THOMAS G PRETLOW
-
依托单位:
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
-
批准号:2097941
-
项目类别:
-
资助金额:$37.75万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
-
批准号:2097939
-
项目类别:
-
资助金额:$33.77万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
BENIGN PROSTATIC HYPERPLASIA AND PROSTATITIS
-
批准号:3247295
-
项目类别:
-
资助金额:$13.4万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
-
批准号:6475794
-
项目类别:
-
资助金额:$37.88万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
-
批准号:2097940
-
项目类别:
-
资助金额:$35.83万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
-
批准号:3549861
-
项目类别:
-
资助金额:$33.5万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
-
批准号:3549860
-
项目类别:
-
资助金额:$33.79万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
-
批准号:6124621
-
项目类别:
-
资助金额:$36.0万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
-
批准号:2412745
-
项目类别:
-
资助金额:$34.21万
-
财政年份:1992
-
负责人:THOMAS G PRETLOW
-
依托单位:
海外基金